In addition, the existence of MUC4 splice variants, autoantibodies against abnormally glycosylated MUC4 and T‐cell clones against MUC4 mutations strengthen its importance as a tumour‐associated antigen in vaccine research.67 This evidence concerns the gene MUC4 and neoplasm.